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Abstract
Background: Human RNase P has been initially described as a tRNA processing enzyme, consisting of H1 RNA and at least
ten distinct protein subunits. Recent findings, however, indicate that this catalytic ribonucleoprotein is also required for
transcription of small noncoding RNA genes by RNA polymerase III (Pol III). Notably, subunits of human RNase P are
localized in the nucleolus, thus raising the possibility that this ribonucleoprotein complex is implicated in transcription of
rRNA genes by Pol I.
Methodology/Principal Findings: By using biochemical and reverse genetic means we show here that human RNase P is
required for efficient transcription of rDNA by Pol I. Thus, inactivation of RNase P by targeting its protein subunits for
destruction by RNA interference or its H1 RNA moiety for specific cleavage causes marked reduction in transcription of rDNA
by Pol I. However, RNase P restores Pol I transcription in a defined reconstitution system. Nuclear run on assays reveal that
inactivation of RNase P reduces the level of nascent transcription by Pol I, and more considerably that of Pol III. Moreover,
RNase P copurifies and associates with components of Pol I and its transcription factors and binds to chromatin of the
promoter and coding region of rDNA. Strikingly, RNase P detaches from transcriptionally inactive rDNA in mitosis and
reassociates with it at G1 phase through a dynamic and stepwise assembly process that is correlated with renewal of
transcription.
Conclusions/Significance: Our findings reveal that RNase P activates transcription of rDNA by Pol I through a novel
assembly process and that this catalytic ribonucleoprotein determines the transcription output of Pol I and Pol III, two
functionally coordinated transcription machineries.
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Introduction
Transcription is carried out by functionally distinct nuclear RNA
polymerases (pols) associated with general transcription factors, as
well as specificity and coregulatory factors that assist in formation
and function of preinitiation complexes. Pol I transcribes rRNA
genes, Pol II mainly synthesizes protein-coding genes, while Pol III
transcribes a large set of small noncoding RNA genes. Recent
findings reveal that noncoding RNAs associate with and regulate
pols I, II and III [1–6]. Thus, U1 snRNA and 7SK RNA regulate
initiation and elongation of transcription by Pol II [7,8], Alu RNA
represses transcription by binding to Pol II in response to heat shock
[9], IGS RNA facilitates silencing of Pol I transcription of rRNA
genes through interaction with the chromatin remodeling complex
NoRC[3],while the H1RNAsubunitofhumannuclear RNasePis
required for Pol III transcription of small noncoding RNA genes
[10,11]. These noncoding RNAs act in the context of ribonucleo-
protein complexes [3,10,12].
Human nuclear RNase P has been initially characterized as a
tRNA processing ribonucleoprotein, consisting of H1 RNA and at
least ten distinct protein subunits, termed Rpp14, Rpp20, Rpp21,
Rpp25, Rpp29, Rpp30, Rpp38, Rpp40, hPop1 and hPop5 [13].
The endonucleolytic activity of human RNase P in tRNA
processing requires its H1 RNA entity, which recognizes precursor
tRNA as substrate [14]. A recent work reports that H1 RNA
mediates cleavage of precursor tRNA in the absence of protein
[15]. Accordingly, the main input of the numerous protein
subunits of human RNase P should be in other complex and
versatile tasks of this ribonucleoprotein complex, e. g. transcription
[11,16], as will be further corroborated in this study.
We have previously demonstrated that human nuclear RNase P
is required for transcription of small noncoding RNA genes
transcribed by Pol III [10,11]. RNase P exerts its role in
transcription through association with Pol III and with chromatin
of Pol III genes, including the 5S rRNA genes whose transcripts
are not known to be processed by RNase P [10]. RNase P acts as
an auxiliary factor for Pol III, as is the case with the transcription
factors TFIIIA, TFIIIB and TFIIIC. This latter concept is based
on the fact that Pol III can catalyze transcription reactions in a
simplified in vitro transcription system in the absence of TFIIIB
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Moreover, Pol III requires only TFIIIB for transcription of tRNA
and 5S rRNA genes in vitro [18,19] and a highly purified human
Pol III combined with recombinant SNAPc and TFIIIB subunits
can direct multiple cycles of in vitro transcription initiation and
termination from a U6 snRNA gene promoter [20].
H1 RNA is an abundant molecule in the cell. This transcript
was detected in the cytoplasm, nucleoplasm and nucleoli. Protein
subunits of human RNase P have also been differentially detected
in specialized intranuclear compartments associated with active
gene transcription, including nucleoli [16]. Mass spectrometry
analysis of highly purified nucleoli of human cells confirms the
existence of many protein subunits of RNase P, including Rpp14,
Rpp20, Rpp25, Rpp29, Rpp30, Rpp38, Rpp40 and hPop1, in
these bodies [21]. Indirect immunofluorescent analyses demarcate
some of these protein subunits in confined sub-nucleolar sites, such
as Rpp29 that resides in the dense fibrillar component, in which
transcription and processing of rRNA take place [22,23]. RNase P
shares its protein subunits with the nucleolar ribonucleoprotein
RNase MRP, except for the subunits Rpp21 and H1 RNA, which
could be used to discriminate between the two ribonucleoproteins
[24]. The exact role of human RNase MRP in the nucleolus
remains unknown while its yeast counterpart is required for
processing of 5.8S rRNA [25].
In this study, we show by biochemical and reverse genetic
means that H1 RNA and its protein subunits, as part of an RNase
P ribonucleoprotein, are required for efficient transcription of
rDNA by Pol I. RNase P copurifies and associates with
components of Pol I and its transcription initiation factors and
exerts its role in transcription through association with the
promoter and coding region of rDNA. Furthermore, we
demonstrate that RNase P disengages from rDNA in mitosis and
reassociates with it at G1 phase through a dynamic and stepwise
assembly process. Our data implicate a catalytic ribonucleoprotein
in transcription by Pol I and Pol III, whose coordinated function is
critical for protein synthesis and cell growth.
Results
Knockdown of protein subunits of human RNase P
inhibits Pol I function
Rpp29 was targeted for destruction in HeLa cells by the use of
RNA interference. Western blot analysis revealed efficient knock-
down of Rpp29 in cells transfected with siRNA29 [26] but not with
luciferase siRNA (Figure 1A, lanes 1–3 versus 4–6). Transcription of
a human mini-rDNA gene, which is composed of rDNA promoter
and adjacent 59ETS segment fused to a terminator region
(Figure 1B), took place in the control whole cell extracts
(Figure 1C, lanes 5–7) but not in those prepared from cells treated
with siRNA29 (Figure 1C, lanes 2–4; Figure 1D). Similarly,
transcription of a human 5S rRNA gene was deficient in the
extracts derived from cells with knockdown of Rpp29 (Figure 1C,
lanes 8–10 versus 11–13), as previously shown [10]. Moreover,
knockdown of Rpp29 by siRNA29 (Figure 1E) caused a marked
decrease in 45S pre-rRNA synthesis in cells, as determined by RT-
PCR (Figure 1E). The primers used for detection of the pre-rRNA
recognize the 59ETS, which is processed quickly from the primary
transcript during transcription and thus reflects transcription
initiation by Pol I. By contrast, expression of the U1 snRNA,
which is transcribed by Pol II, remained unchanged (Figure 1E).
Inhibition of Pol I and Pol III transcription is not restricted to
knockdown of Rpp29. Thus, knockdown of the subunit Rpp21,
which is not shared with RNase MRP, by either siRNA or external
guide sequence (Figure 2A)[26] resulted in ,90% reduction in
transcription of the mini-rRNA and 5S rRNA genes (Figures 2B–
D). More importantly, nuclear run-on transcription assays
confirmed that the level of nascent transcription of endogenous
rRNA genes decreased by 5- and 10-fold in cells treated with
siRNA21 and EGS
Rpp21, when compared with control cells
(Figure 2E). A more prominent reduction (,34-fold) in the level of
nascent transcription of 5S rRNA gene by Pol III was measured
(Figure 2E). Since this nascent transcription reflects the amount of
active polymerases on the tested template, the results indicate that
RNase P determines the transcription output by Pol I and Pol III.
Reconstitution assays of Pol I transcription
Knockdown of Rpp21, Rpp29 or Rpp38 by RNA interference has
beenshowntobeaccompaniedby coordinateinhibitionofexpression
of other protein subunits of human RNase P [26,27; also data not
shown]. This phenomenon made the development of an in vitro
reconstitution system for Pol I and Pol III transcription using defined
protein components of RNase P unfeasible. However, knockdown of
the subunit Rpp25 by siRNA [26] led to moderate inhibition of
expression of only two subunits, Rpp20 and Rpp21 (Figures 3A and
3B; and data not shown), while it resulted in severe inhibition of
transcription of the mini-rRNA gene (Figure 3C, lanes 2 and 3 versus
4a n d5 )a n d5 Sr R N Ag e n e(F i g u re3 D ,la n e s2a n d3v e r s u s4a n d5 ) .
Therefore, we checked if transcription in these extracts can be
rescued by a histidine-tagged, recombinant Rpp25 protein that was
highly purified through a chelating chromatography column
(Figure 3G). Remarkably, the addition of recombinant Rpp25 (see
Materials and Methods) to whole extracts obtained from cells with
knockdown of Rpp25 resulted in reconstitution of transcription of the
mini-rRNA and 5S rRNA genes, when compared with transcription
in untreated extracts (Figures 3C and 3D, lanes 6 and 7 versus 2 and
3). The gain-of-function of Pol I transcription was partial (Figure 3E)
while that of Pol III transcription was moreprominent (Figure3F;see
below). The addition of recombinant Rpp25 to extracts of mock-
transfected cells had no comparable consequences on transcription
(Figures 3C and 3D, lanes 8 and 9 versus 4 and 5). The addition of
recombinant Rpp20 protein (Figure 3G) had no effect on
transcription (Figure 3D, lane 10 versus 2), while inclusion of
recombinant Rpp20 and Rpp25 or recombinant Rpp20, Rpp21 and
Rpp25 proteins rather reduced transcription (Figure3D, lanes 11 and
12versus 2). Rpp20 and Rpp25belongto the Alba-likesuperfamily of
chromatin proteins [28] and it seems that the former protein
neutralizes the effect of Rpp25 on transcription.
Flow cytometry analysis revealed a decrease in the proliferation
of the cells described above after 2 and 3 days in culture, in which
cells reached high confluence (data not shown), and thus exhibited
reduced activity of Pol I (Figure 3C, lane 4 versus 5). This
reduction in Pol I activity may have counteracted the effect of
recombinant Rpp25 in reconstitution assays. Therefore, we
repeated the reconstitution experiment as described in Figure 3C
but this time we included a 24 h time point, in which knockdown
of Rpp25 was evident (Figure 3H). The results show that the
addition of recombinant Rpp25 to the extract obtained at 24 h
time point brought to almost full recovery of transcription of the
mini-rRNA gene, when compared to transcription in extracts
obtained at later time points (Figure 3I).
The findings described above provide evidence that a protein
subunit of human RNase P can substitute for its endogenous
counterpart by reconstituting transcription of Pol I and Pol III.
Protein subunits and H1 RNA are required for efficient
Pol I transcription
Immunodepletion of active RNase P from whole HeLa extracts by
the use of polyclonal antibodies directed against Rpp20 and Rpp25
RNase P in Pol I Transcription
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80% in transcription of the mini-rRNA gene, which could be restored
by adding back their corresponding immunoprecipitates (Figure 4A).
Moreover, targeted cleavage of the H1 RNA moiety in whole HeLa
extracts by RNase H and an antisense deoxyoligonucleotide H1-1,
which is directed against the specificity domain of H1 RNA
(Figure 4B), caused incorrect processing of the 59 leader sequence
of precursor tRNA
Tyr by RNase P (Figure 4C, lane 3 versus 2; arrow
head) and abolished transcription ofthe mini-rDNA gene (Figures 4D
and 4E). By contrast, the use of a scrambled H1-1 oligonucleotide,
H1-1sc,didnotalterenzymespecificity(Figure4C,lane4versus2)or
transcription (Figures 4D and 4E). Similar results were obtained for
transcription of the 5S rRNA gene (Figures 4D and 4E). Neither
RNase H nor oligonucleotides alone had an effect on RNase P or
transcription (data not shown; ref. 10). Since H1 RNA discriminates
RNase P from RNase MRP, the results establish that the former
ribonucleoprotein, containing an intact H1 RNA, is implicated in
transcription by Pol I.
Figure 1. Knockdown of Rpp29 by siRNA causes inhibition of Pol I transcription. A. HeLa cells were transfected with siRNA29 or luciferase
siRNA (see Materials and Methods), whole extracts were then prepared from cells at 24, 48 and 72 h after transfection and examined by Western blot
analysis for Rpp29 and b-actin. Positions of proteins are depicted. B. A scheme of the human mini-rDNA gene. This construct has a rDNA gene
promoter (from position 2500) and 59ETS (position +382) that was subcloned in pBluescript in which a rDNA terminator region, consisting of 57-bp
39ETS, Sal I box and 51-bp IGS, was inserted. The 59ETS is 382 bp in length and harbors no known cleavage site, including the A9 site. Arrow points to
the transcription initiation site. C. Transcription of the mini-rRNA and 5S rRNA genes in extracts described in A. Labeled RNA was separated in 8%
polyacrylamide/7 M urea gel and subjected to autoradiography. Lanes 1–7 represent exposure for longer time than that of lanes 8–13. Positions of
the 432-nt mini-rRNA (lanes 2–7) and 120-nt 5S rRNA (lanes 8–13) transcripts are shown. Asterisk represents endogenous but unknown labeled RNA.
D. The optical density (in arbitrary units) of the mini-rRNA band seen in lanes 2–7 of panel C. E. HeLa cells were treated with siRNA29 or luciferase
siRNA for 48 h and knockdown of Rpp29 was tested by Western blot analysis (left panel). GAPDH was used as internal control. Total RNA was
extracted from cells and subjected to RT-PCR analysis of 59ETS and U1 snRNA (see Materials and Methods). As negative control, RNA was treated with
RNase A before reverse transcription of the 59ETS (right panel). PCR products were separated in agarose gels.
doi:10.1371/journal.pone.0004072.g001
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Pol I and its transcription factors
To check if RNase P is associated with Pol I, S100 extracts of
HeLa cells were fractionated in a DEAE-Sepharose anion
exchange chromatography column [13; see Materials and
Methods] and the eluted fractions with the peak of RNase P
activity were then purified in a hydrophilic Sephacryl S-100 gel
filtration column [14]. The excluded fractions were assayed for
RNase P activity in tRNA processing (Figure 5A) and tested for the
presence of Rpp29 and Rpp25 (Figure 5B; lower panels).
Components of Pol I, such as RPA194 and RPA43, and its
associated transcription factors, including the upstream transcrip-
tion factor UBF and the TBP-associated factor TAFI110, were all
detected in fractions F26-F30 enriched with RNase P (Figure 5B).
Moreover, active RNase P is physically associated with RPA43,
RPB8, UBF and TAFI110 in these fractions as revealed by
coimmunoprecipitation experiments (Figure 5C, lanes 4–7).
The above findings demonstrate that an active RNase P
associates with components of Pol I, which seems to exist in a large
complex with its transcription initiation factors. The purification of
a large (Mr.2000 kDa) murine Pol I holoenzyme with its
transcription factors has been reported [29].
RNase P and Pol I are located at the promoter and coding
region of rDNA
To have a mechanistic explanation of how human RNase P acts
with Pol I in rRNA gene transcription, we tested if the former
multi-protein complex associates with rDNA in rapidly dividing
HeLa cells by chromatin immunoprecipitation (ChIP) analysis (see
Materials and Methods)[10]. Genes for rRNA are organized in
Figure 2. Knockdown of the specific subunit Rpp21 inhibits transcription and pre-rRNA synthesis. A. HeLa cells were transfected with a
plasmid expressing EGS
Rpp21 or siRNA21 or mocked transfected for 48 h. Whole HeLa extracts were then prepared and tested for the presence of
Rpp21 and b-actin by Western blot analysis. B. Transcription of the mini-rRNA and 5S rRNA genes in extracts described in A and the reaction products
were analyzed as in Figure 1C. C and D. The bands of the mini-rRNA and 5S rRNA were quantitated and plotted. E. Nuclear run-on transcription
analysis (see Material and Methods) of the human 59ETS rRNA and 5S rRNA genes in mock-, EGS
Rpp21- or siRNA21-treated HeLa cells. Letter P indicates
pBluescript background.
doi:10.1371/journal.pone.0004072.g002
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expressing siRNA25 or mock transfected (see Materials and Methods), whole extracts were then prepared from cells at 48 and 72 h after transfection
and examined for Rpp25, Rpp20 and b-actin by Western blot analysis. Positions of proteins are depicted. B. Same as in A but transfection was for 72
and 96 h and proteins tested were Rpp25, Rpp20 and Rpp21. C. Reconstitution assays of transcription of the mini-rRNA gene in extracts described in
A were performed in the absence or presence of recombinant Rpp25 protein. The resulted 432-nt mini-rRNA was analyzed as in Figure 1C. Exposure
time was for 96 h. D. Reconstitution of a human 5S rRNA gene transcription in extracts described in B in the absence or presence of recombinant
Rpp25 protein. As controls, recombinant Rpp20 and Rpp21 proteins were used. The resulted 120-nt 5S rRNA was analyzed as in Figure 1C. Asterisk
indicates endogenous tRNA labeled with radioactive nucleotide. E. The 432-nt mini-rRNA bands seen in C were quantitated and the optical density
(in arbitrary units) was plotted. F. The 120-nt 5S rRNA bands seen in D were quantitated and the optical density (in arbitrary units) was plotted. G.
RNase P in Pol I Transcription
PLoS ONE | www.plosone.org 5 December 2008 | Volume 3 | Issue 12 | e4072Figure 4. H1 RNA and protein subunits of RNase P are required for Pol I transcription in extracts. A. Whole HeLa extracts were subjected
to immunodepletion analysis using 200 mL of serum containing polyclonal rabbit antibodies against Rpp20, Rpp25 or p53. Transcription reactions in
the immunodepleted extracts (grey bars) or in extracts reconstituted with their corresponding immunoprecipitates (black bars) were carried out
using the mini-rDNA gene and labeled RNAs were analyzed as described in Figure 1C. The 432-nt mini-rRNA band was quantitated and the optical
density (in arbitrary units) was plotted. B. A proposed secondary structure of H1 RNA and the nucleotide sequence against which the antisense H1-1
deoxyoligonucleotide was directed. The upper half of H1 RNA represents the specificity domain. Conserved domains, including the P4 pseudoknot in
the lower (catalytic) domain are shown. C. Whole HeLa extracts (15 mg/ml) were incubated with 8 mg of H1-1 (lane 3) or scrambled H1-1sc (lane 4)
deoxyoligonucleotide in the presence of RNase H for 45 min as described [10]. Extracts were then assayed for RNase P activity in processing of
32P-
precursor tRNA
Tyr, and cleavage products were analyzed in an 8% sequencing gel. The 59 leader sequence (59) and shorter species (arrow head)
generated as a result of substrate miscleavage, are indicated. A concentrated DEAE-purified RNase P preparation (Ctrl; lane 2) was used as control for
the correct cleavage of the substrate. D. Whole HeLa extracts described in C were subjected to transcription of the mini-rDNA gene and 5S rRNA
genes as described in Figure 1C. E. Optical density of the mini-rRNA and 5S rRNA bands seen in panel D.
doi:10.1371/journal.pone.0004072.g004
Coomassie blue staining of purified, histidine-tagged rRpp20, rRpp21 and rRpp25 proteins analyzed in 12% SDS/PAGE. Positions of the protein size
markers (M) are shown. H. Same as in B but transfection time points were 24, 48 and 72 h. I. Transcription assays of Pol I in the absence and presence
of recombinant Rpp25 protein were done as described in C. The 432-nt mini-rRNA band was quantitated and the optical density (in arbitrary units)
was plotted. Reconstitution assays described here have been repeated 3 times with different time points and produced similar results.
doi:10.1371/journal.pone.0004072.g003
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and each unit has 18S, 5.8S and 28S rRNA coding regions that
are interspersed by internal and external transcribed spacers
(Figure 6A). ChIP analysis revealed 5.8S rDNA in chromatin
samples brought down by antibodies directed against Rpp20,
Rpp21 (not shared with RNase MRP), Rpp29 and Rpp38
(Figure 6B, lanes 2–5, respectively), as well as RPB8 (Figure 6B,
lane 6), a core protein component of Pol I (also of Pol II and III).
No PCR product was seen when preimmune rabbit serum or
antibody directed against the tumor suppressor p53 were tested
(Figure 6B, lanes 7 and 8). A human tRNA
Tyr gene was detected in
chromatin samples brought down by antibodies against Rpp20,
Rpp21 and Rpp29 (Figure 6B, lanes 2–4) but not Rpp38
(Figure 6B, lane 5), consistent with previous findings [10]. The
U1 snRNA gene, which is transcribed by Pol II, was enriched in
chromatin precipitated by the antibody against RPB8 (Figure 6B,
Figure 5. Pol I components copurify and associate with human RNase P. A. A DEAE-purified RNase P was loaded (L, load) into a Sephacryl S-
100 gel filtration column and eluted fractions were assayed for RNase P activity in processing of
32P-labeled precursor tRNA
Tyr (S) to mature tRNA (39)
and 59 leader sequence (59). Substrate cleavage was analyzed as in Figure 4C with control HeLa RNase P (Ctrl). B. Western blot analysis of Sephacryl S-
100 eluted fractions using antibodies against RPA194, RPA43, TAFI110, UBF, Rpp29 and Rpp25. Preparations of DEAE-purified RNase P (first lane) was
used as control for input. Proteins were separated in 12% SDS/PAGE and the positions of the corresponding proteins and the protein size markers are
shown. C. Fraction F28 described in A was subjected to immunoprecipitation analysis using antibodies against Rpp29 (lane 3), RPA43 (lane 4), UBF
(lane 5), TAFI110 (lane 6), RPB8 (lane 7) and IgG (lane 8) in the presence of 150 mM KCl (IP150). For Rpp29 and RPA43 immunoprecipitation was also
performed at 300 mM KCl (lanes 9 and 10). Immunoprecipitates obtained were tested for RNase P activity in processing of a
32P-labeled precursor
tRNA
Tyr (S). RNase P in fraction F28 was tested as control for enzyme activity (lane 2) and cleavage products were analyzed as in A.
doi:10.1371/journal.pone.0004072.g005
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detected in any chromatin sample (Figure 6B, lanes 2–8).
Chromatin occupancy of 5.8S rDNA by Rpp25 was almost
eliminated in cycling HeLa cells transfected with siRNA25 for
48 h, when compared with cells treated with luciferase siRNA
(Figure 6C, lane 2 versus 8), while that of Rpp20, Rpp29 and
RPB8 showed no comparable decline (Figure 6C). Hence, binding
of Rpp25 to rDNA loci is independent of that of other protein
subunits of RNase P and Pol I.
We next scanned the human rDNA transcription units (each is
,14 Kbp) for binding of protein subunits of RNase P by ChIP
analysis using specific primers that correspond to distant regions
within these units (see Figure 6A). In these experiments, the
genomic DNA was sheared to small pieces of ,500 bp to allow
high resolution of chromatin binding regions (data not shown).
Surprisingly, we found that Rpp20, Rpp21, Rpp29 and Rpp30
associated with the promoter region, in addition to the coding
region spanning 18S rDNA and 28S rDNA (Figure 6D, lanes 1–4).
Similarly, RPA194, a protein subunit of Pol I, bound to the
promoter and coding region of rDNA (Figure 6D, lane 5),
consistent with previous findings reported by others [32]. RPA194
did not bind to the intergenic sequence located ,5 Kbp
downstream of the terminator region of rDNA, which was also
the case with the protein subunit of RNase P, except for Rpp29
that showed weak signal of binding (Figure 6D, lower panel). This
latter finding rules out the possibility that RNase P is distributed
uniformly on rDNA repeats.
Dissociation and reassociation of RNase P with chromatin
of rDNA during the cell cycle
Transcription of rRNA genes is regulated during the cell cycle,
whereby it gradually increases from G1 to S phase, peaks at G2
and ceases at mitosis [33,34]. To show that RNase P associates
with transcriptionally active rRNA genes, HeLa cells were
synchronized to G2/M by treatment with nocodazole, a
microtubules depolymerization inhibitor, and then the separated
G2 and M cell populations [35; see Materials and Methods] were
subjected to flow cytometry (Figure 7C) and ChIP analyses. Rpp21
and Rpp29 were associated with 5.8S rDNA and 18S rDNA in G2
cells but fully or partially disengaged from these loci in mitotic cells
(Figure 7A, lanes 2 and 3 versus 7 and 8, respectively). Moreover,
chromatin occupancy of these pre-rRNA coding regions by RPB8,
which represents Pol I, was evident in cells at G2 but not at M
phase (Figure 7A, lane 4 versus 9), an observation that is consistent
Figure 6. Protein subunits of RNase P occupy the promoter and coding region of rDNA. A. Structure of a rRNA gene, showing 18S, 5.8S
and 28S rRNA flanked by 59ETS and 39ETS and intervened by ITS1 and ITS2. RNase MRP cleaves at the A3 site in the ITS1. Small arrows indicate
locations of primers used for PCR. B. ChIP was performed with rapidly dividing HeLa cells using affinity-purified polyclonal antibodies against Rpp20
(lane 2), Rpp21 (lane 3), Rpp29 (lane 4), Rpp38 (lane 5), RPB8 (lane 6), preimmune serum (lane 7) or p53 (lane 8). DNA of the precipitated chromatin
was analyzed by PCR for the presence of 5.8S rDNA, tRNA
Tyr, U1 snRNA and ARPP P0 genes. Positive PCR products for each gene using 0.01, 0.1 and
1% of input DNA are shown (lanes 9–11). This panel is a composite of two mini-agarose gels with the same exposure time. C. HeLa cells were
transfected with siRNA25 (lanes 1–6), which caused marked knockdown of Rpp25 (data not shown), or with control luciferase siRNA (lanes 7–12) for
48 h. ChIP analysis was then performed for 5.8S rDNA and U1 snRNA gene using antibodies against Rpp20, Rpp25, Rpp29, Rpp38, RPB8 and
preimmune serum. Positive PCR reactions using 0.01, 0.1 and 1% of input DNA are shown (lanes 13–18). D. ChIP analysis was performed with cells as
in B using antibodies against Rpp20 (lane 1), Rpp21 (lane 2), Rpp29 (lane 3), Rpp30 (lane 4), RPA194 (lane 5), preimmune serum (lane 6) or p53 (lane
7). DNA of the precipitated chromatin was analyzed by PCR for the presence of the promoter, 18S, 5.8S, 28S or IGS DNA using the corresponding
primers shown in A. Positive PCR reactions for each rDNA region using 0.01, 0.1 and 1% of input DNA are shown (lanes 8–10).
doi:10.1371/journal.pone.0004072.g006
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nocodazole for 16 h. Mitotic cells were separated from adhered G2 cells as described [35]. ChIP was performed with G2 (G2) and mitotic (M) cells
using antibodies against Rpp21 (lanes 2 and 7), Rpp29 (lanes 3 and 8), RPB8 (lanes 4 and 9), preimmune serum (lanes 5 and 10) or p53 (lanes 6 and
11). Detection of 5.8S rDNA and 18S rDNA was done as in Figure 6D. Positive PCR reactions using 0.01, 0.1 and 1% of input DNA are shown (lanes 12–
17). The PCR signal of Rpp29 seen in mitotic cells (lane 8) was not seen in two other independent experiments (data not shown) and hence its
presence may be related to incomplete separation of M and G2 cells. B. As in A but Rpp30, Rpp38, Rpp40, RPB8 and preimmune serum were tested in
ChIP. The U1 snRNA gene that is transcribed by Pol II was tested as control. C. FACS analysis of cells described in C. Asynchronous HeLa cells were
used as control. D. Western blot analysis of whole extracts prepared from G2 and M cells described in C by using affinity-purified antibodies directed
against the indicated protein subunits of human RNase P. Rpp14 and hPop5 were difficult to detect (data not shown). Mitotic cyclin B1 and b-actin
were analyzed as control.
doi:10.1371/journal.pone.0004072.g007
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of RNase P, including Rpp30, Rpp38 and Rpp40, were bound to
rDNA in G2 cells but not in mitotic cells (Figure 7B, lanes 1–3
versus 6–8 and data not shown). Western blot analysis showed that
the expression of some protein subunits, such as Rpp29 and
Rpp38, decreased in mitotic cells, when compared with G2 cells,
while that of Rpp20 and Rpp40 remained largely unchanged
(Figure 7D; see below). This implies that the detachment of these
protein subunits from rDNA in mitosis is a shared property but
their fate is not interrelated (see below).
We next investigated the recruitment of protein subunits of
RNase P after mitosis in synchronized HeLa cells. Strikingly, we
found that Rpp20 and Rpp29 reassociated with 5.8S rDNA after
2 h of exit of synchronized HeLa cells from mitosis (Figure 8A,
lanes 1 and 3) but Rpp25 did not (Figure 8A, lane 2). Similar
pattern of chromatin occupancy by these three subunits was
observed when the 5S rRNA gene was analyzed (Figure 8A, lanes
1–3; middle panel), while both Rpp29 and Rpp25 were not
detected at the tRNA
Leu gene until mid G1 (Figure 8A, lanes 2 and
3 versus 8 and 11). Therefore, recruitment of Rpp20, Rpp25 and
Rpp29 to chromatin is not interdependent. Of note, RPB6
promptly bound to 5.8S rDNA, 5S rRNA and tRNA
Leu genes at
early G1 (Figure 8A, lanes 4, 9 and 13) even though this binding
does not reflect vigorous Pol I transcription, since it has been
shown that UBF is inactivated at early G1 [33,34]. Indeed,
transcription of human tRNA
Tyr and 5S rRNA genes was also
impaired at early G1 (Figures 8C and 8D, lane 2 versus 3) but
gradually increased as the synchronized cells (Figure 8B) pro-
gressed to S phase (Figures 8C and 8D, lanes 3–6). By contrast,
binding of Rpp20 to chromatin of 5S rRNA and tRNA
Leu genes
somewhat decreased at S phase (Figure 8A, lane 10 versus 1 and 6)
The aforementioned observations raised the question if the
biosynthesis of the protein subunits of human RNase P during the
cell cycle correlates with chromatin binding by RNase P and with
the transcriptional activity of Pol I and Pol III. Thus, the steady
state levels of several protein subunits of RNase P were determined
in synchronized HeLa cells that were released from hydroxyurea,
which arrests cells at G1/S phase (Figure 8E). Expression of
Rpp25 and Rpp29 increased during the S phase, peaked at G2,
declined at mitosis and recovered at G1 (Figure 8F, lanes 1–9).
This pattern agrees with the reported activity of Pol I and Pol III
during the cell cycle [34,35]. However, we found that the
expression of Rpp20 and Rpp40 rather remained largely
unchanged throughout the phases of the cell cycle, including
mitosis (Figure 8F, lanes 1–9), in which these subunits also
detached from chromatin (data not shown). Hence, the biosyn-
thesis of these latter protein subunits does not reflect their dynamic
binding to chromatin or transcription during the cell cycle.
Taken together, the results described above indicate that
restoration of Pol I and Pol III transcription after mitosis is not
correlated with the recruitment of a fully preassembled RNase P
on rDNA and small noncoding RNA genes. To the contrary, its
assembly involves a dynamic and stepwise association process,
which includes two Alba-like chromatin proteins, Rpp20 and
Rpp25.
Discussion
We have shown that human RNase P is required for efficient
transcription of rDNA by Pol I. Thus, inactivation of RNase P by
targeting its protein and RNA subunits for destruction inhibits
rRNA gene transcription by Pol I, an indication that this complex
acts in the form of ribonucleoprotein. RNase P associates with
components of Pol I and its transcription factors and affects
nascent transcription by Pol I, as well as Pol III. RNase P binds to
chromatin of the promoter and coding region of rRNA genes.
Chromatin occupancy by RNase P is dependent on active
transcription of rRNA genes and is linked to the cell cycle.
Combined with the role of RNase P in Pol III transcription and
binding to chromatin of 5S rRNA and tRNA genes [10,11], the
data presented in this study suggest that this chromatin-associated
complex is critical for the coordinate regulation of ribosome
biogenesis and protein translation.
A novel role for RNase P in the nucleolus
In S. cerevisiae, the majority of the RNase P RNA exists in the
nucleolus, in which clustering of tRNA genes and processing of
precursor tRNAs take place [37]. In situ RNA hybridization
analysis also visualized H1 RNA in the nucleolus, thus raising the
possibility that RNase P may be functional in ribosome biogenesis.
Our study establishes that a functional human RNase P exists in
the nucleolus and that it is implicated in transcription of rRNA
genes. ChIP analysis demonstrates that many protein subunits of
RNase P, including its subunit Rpp21 that is not shared with
RNase MRP, bind to chromatin of transcriptionally active rDNA
loci. This nucleolar form of RNase P is comparable, in terms of its
protein composition, to that initially characterized as a tRNA
processing holoenzyme [13].
In yeast, processing of rRNA is coordinated in a transcription-
dependent manner [38–40]. Yeast Pol I associates with a nucleolar
substructure that is active in the synthesis and processing of rRNA
[41] and it has been demonstrated that transcription and
processing of rRNA are coordinated through specific components
of the small ribosomal subunit processome [38,40,42]. However,
human RNase P does not act on transcription of rDNA as a
processing factor. First, the mini-rRNA gene construct was
designed to have a rDNA promoter fused to adjacent 59ETS
segment, which has no known cleavage sites that could recruit
processing factors at the transcript level. Nonetheless, transcription
driven by this promoter is inhibited in extracts lacking functional
RNase P, as a result of depletion of its subunits, including H1
RNA and Rpp21 that are not shared with RNase MRP. In fact, it
has been shown that transcription and processing factors are
recruited separately in mammalian cells [39,43]. Second, RNase P
binds to the promoter region of rDNA and associates with
components of the transcription initiation machinery, e. g. Pol I,
UBF and SL1 complex, suggesting that it is involved in
transcription initiation. Third, RT-PCR analysis of 59ETS unveils
a substantial reduction in pre-rRNA synthesis in cells having
inactive RNase P. 59ETS is known to be processed rapidly and
cotranscriptionally from the primary transcript of rRNA and thus
reflects transcription initiation by Pol I.
Assembly of a chromatin-associated RNase P and its link
to the cell cycle
Binding of RNase P to chromatin of rDNA is dynamic in the
sense that it is linked to transcription and the cell cycle. In mitosis,
RNase P detaches from chromatin of rDNA, which concurs with
cessation of transcription, while most of the protein subunits of
RNase P were found to be associated with chromatin of rDNA at
G2 phase, in which transcription by Pol I is elevated. At early G1,
however, not all the protein subunits of RNase P are equally
reassociated with chromatin of rDNA. For example, Rpp20 and
Rpp29 but not Rpp25 are promptly recruited to rDNA after exit
from mitosis, while Rpp25 binds to rDNA loci at the S phase (or
late G1), which coincides with increased transcription by Pol I.
Accordingly, Rpp25 seems to contribute to the elevated activity of
Pol I at S phase (or late G1), a conclusion that is supported by the
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in whole cell extracts lacking endogenous Rpp25. Similarly,
recruitment of RNase P to 5S rRNA and tRNA genes after mitosis
proceeds via a dynamic and stepwise association process of its
subunits.
A line of evidence supports the prospect that protein subunits of
human RNase P could be recruited as independent entities to
chromatin of target genes. Thus, RNA interference shows that
knockdown of one protein subunit does not necessarily obstruct
the recruitment of other subunits on target genes in cycling cells,
even though transcription is inhibited. For example, knockdown of
Rpp25 did not lead to disengagement of Rpp20 and Rpp29 from
rDNA (Figure 6C) and knockdown of Rpp29 did not affect
chromatin occupancy of tRNA and 5S rRNA genes by Rpp21
[10]. Moreover, Rpp21 and Rpp29 differentially disengage from
chromatin of tRNA and 5S rRNA genes in response to cessation of
proliferation of cells [10]. Another research group showed that
Rpp29 rapidly shuttles between the nucleoplasm and nucleolus,
suggesting that this core component of RNase P is highly dynamic
and not permanently bound to a fixed RNase P [44]. That RNase
P is recruited as individual subunits (or partial sub-complexes) is
consistent with the finding that subunits of Pol I rapidly and
massively enter the nucleolus as distinct subunits rather than as
part of a preassembled holoenzyme [45] and that the assembly of
Pol I proceeds via a sequential manner in each transcription cycle
[39,45]. More importantly, it has been shown that the recruitment
efficiency and retention of Pol I components at the promoter
region of rDNA is used to control the transcriptional output of
rRNA genes [46]. Apparently, these latter findings contrast the
existence of assembled holoenzymes of Pol I [29] and RNase P
[13]. Nonetheless, the purified Pol I-RNase P complex described
in this study may constitute the fraction of these holoenzymes that
have already been assembled and/or engaged in transcription.
Nuclear run-on transcription assays indicate that the rate of
nascent transcription of rDNA and 5S rRNA genes, which reflects
the number of active Pol I and Pol III on these genes, is reduced in
cells with inactivated RNase P. Thus, RNase P determines the
output of transcription by active polymerases. Remarkably, ChIP
analysis showed that chromatin occupancy by Pol I and Pol III (as
represented by the core components RPB6 and RPB8) did not
change perceptibly in cells with inactivated RNase P (Figure 6C;
also refs. 10 and 11), an indication that these two polymerases can
be recruited to their corresponding templates, even though there is
no active transcription. Accordingly, RNase P defines those
polymerases that are engaged in active transcription. However, the
exact role of RNase P that is engaged in transcription remains
unknown. This complex can act as auxiliary transcription factor,
chromatin modifier or as new type of chromatin remodeling
complex. In the latter case, it has been shown that RNase P has an
ATPase activity embedded within its Rpp20 subunit [47] but this
chromatin-associated subunit is not related to the SNF2-like
ATPases. Nonetheless, binding of RNase P to the entire rDNA
transcription unit (Figure 6D) could also suggest that this complex
has multiple roles in the various steps of transcription by Pol I.
Finally, binding of a large ribonucleoprotein complex, such as
human RNase P with its two Alba-like proteins, Rpp20 and
Rpp25, to chromatin of hundreds of genes transcribed by Pol I
and Pol III should have global effects on the structure, spatial
organization and function of the genome [48]. As RNA can act as
a scaffold, recruiting factor or sequence-specificity factor in the
modification and function of chromatin [49], elucidation of any
potential role of H1 RNA of RNase P in this regard is of particular
interest.
Materials and Methods
Cell transfection, synchronization and flow cytometry
analysis
Adherent HeLa cells were grown in high glucose DMEM
(Invitrogen) supplemented with 5% fetal bovine serum, strepto-
mycin (100 mg/ml), penicillin (100 U/ml) and Nystatin (12.5 U/
ml). Cells were incubated in 5% CO2 at 37uC. For transfection, 1–
5610
5 cells grown in 92617 mm style petri dishes were
transfected with the desired siRNA (15–30 mg/dish) or plasmid
DNA (15 mg) in 10 ml medium using the calcium phosphate
method. For knockdown of Rpp21 and Rpp25, plasmids (10–
15 mg) carrying siRNA-coding genes (kind gifts of Prof. Sidney
Altman)[26] were introduced into cells.
For synchronization, HeLa cells were grown in 92617 mm style
petri dishes for 50% confluence and then treated with nocodazole
(40 ng/ml) for 16 h. The dishes were shaken to detach mitotic cells
from G2-enriched, adhered cells as described by White et al. 1995
[ref. 35]. Synchronization of cells by hydroxyurea (2.5 mM) was
for 16 h. Cells were released from the inhibitor by replacing the
medium with warm, fresh one. After time points indicated in each
experiment the cells were then stained with propidium iodide for
DNA content analysis by fluorescence-activated cell sorter. Whole
cell extracts were prepared as described [10]. Protein concentra-
tions in extracts were 10–15 mg/ml.
RT-PCR analysis
Reverse transcription was performed using M-MLV reverse
transcriptase (Promega) with equal amounts of total RNA (1–2 mg)
extracted from treated HeLa cells and 5–10 pmol of gene-specific
reverse primers (see below). Amplification of the 59ETS sequence
of the reverse-transcribed pre-rRNA by PCR was performed as
Figure 8. Reassociation of protein subunits of RNase P with chromatin of target genes. A. HeLa cells were synchronized by nocodazole for
16 h before mitotic cells were separated from adhered G2 cells. Mitotic cells were released from the inhibitor for 2, 6 and 14 h. Cells were at early G1,
mid G1 and S phase as determined by flow cytometry analysis (data not shown). ChIP was then performed with synchronized cells using antibodies
against Rpp20 (lanes 1, 6 and 10), Rpp25 (lanes 2, 7 and 11), Rpp29 (lanes 3, 8 and 12), RPB6 (lanes 4, 9 and 13) or control IgG antibody (lane 5). DNA
extracted from the precipitated chromatin was analyzed by PCR for the presence of 5.8S rDNA, 5S rDNA and tRNA
Leu genes. Linear PCR reactions
using 0.01, 0.1 and 1% of input DNA are shown (lanes 14–22). B. HeLa cells were synchronized as described in A and at the indicated time points after
release from nocodazole they were subjected to FACS analysis. C. Whole extracts obtained from HeLa cells described in B were examined for
transcription of a human tRNA
Tyr gene as previously described [10]. The resulted primary transcript is 112 nt in length and has an intron that is
promptly excised to release the exons with 59 leader and 39 trailer sequences (42 and 50 nt in length, respectively). The exons are ligated to produce
a 92-nt intermediate precursor tRNA
Tyr, which is processed by RNase P to remove the 59 leader sequence (5 nt) and by a 39 endonuclease that
eliminates the 39 trailer sequence (11 nt) to generate a mature 76-nt tRNA
Tyr. D. Whole HeLa extracts described in B were assayed for 5S rRNA gene
transcription. E. HeLa cells were synchronized to G1/S phase by treatment with hydroxyurea for 16 h. Cells were then released from inhibitor and
analyzed by FACS for their DNA content at the indicated time points. Cells were at mitosis at 12 h. F. Western blot analysis of whole extracts obtained
from cells described in E using antibodies against Rpp29, Rpp25, Rpp20 and Rpp40 and cyclin B1. Cell cycle progression shown on the top was
deduced from the FACS data shown in E and from the levels of cyclin B1. Similar results were obtained in three independent synchronization
experiments.
doi:10.1371/journal.pone.0004072.g008
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Dimethyl sulfoxide (DMSO). Reverse transcription and PCR
amplification of U1 snRNA was done using primers described
previously [10].
Purification and analysis of human RNase P
Rapidly dividing HeLa cells (at ,50% confluence) in sixty 175-
cm square flasks were pelleted, disrupted, and the cell homogenate
was centrifuged at 7,000 rpm followed by another centrifugation
at 31,000 rpm in a Beckman Ti60 rotor to obtain S100 crude
extract [13]. This S100 extract was loaded on a DEAE-Sepharose
anion exchange chromatography column equilibrated with buffer
A that contains 10 mM Tris-HCl, pH 8.0, 100 mM KCl, 2.5 mM
MgCl2 and 1 mM DTT. RNase P was then eluted from the
column using a 100–500 mM KCl gradient [13]. RNase P activity
in the eluted fractions was examined by processing of the 59 leader
of a
32P-labeled E. coli precursor tRNA
Tyr. RNase P activity is
eluted at 250–300 mM KCl [13], and therefore it coelutes with
Pol I [51]. However, these fractions enriched with RNase P and
Pol I are inactive in transcription of a mini-rRNA gene (data not
shown), most likely because TIF-IA dissociates from Pol I in the
presence of MgCl2 [51], which was included in buffer A. Fractions
enriched with active RNase P were then pooled, concentrated and
fractionated in Sephacryl S-100 HR chromatography column with
protein size markers [14]. Volumetric flow rate of the gel filtration
column was set at ,0.8 ml/min. The eluted fractions were
assayed for the presence of active RNase P as described above.
RNase P eluted as a large particle from the column (with
fractionation range of Mr=1 610
5) in the void volume.
In vitro transcription of Pol I and Pol III and reconstitution
assays
In vitro transcription reactions of the mini-rRNA gene in newly
prepared whole HeLa extracts were performed in a final volume of
25 ml that contained 15 ml of extract, 16 transcription buffer
(12 mM Tris-HCl at pH 7.9, 5 mM MgCl2, 80 mM KCl,
0.5 mM DTT, 10 mM creatine phosphate), NTPs (0.66 mM
ATP, 0.66 mM CTP, 0.66 mM GTP, 0.01 mM UTP), 5 mCi of
[a-
32P]-UTP (3000 Ci/mmol; Amersham) and 0.25 mg of plasmid
carrying the mini-rDNA gene. After 1 h of incubation at 30uC,
reaction mixtures were diluted 1:1 with H2O, passed through a G-
50 column, diluted to 250 ml with 16 digestion buffer (20 mM
Tris-HCl, pH 7.9, 250 mM sodium acetate, 1 mM EDTA, 0.25%
SDS), and digested with 120 mg/ml Proteinase K for 30 min at
37uC. RNA was recovered following phenol:chloroform:isoamy-
lalcohol extraction by ethanol precipitation and labeled RNAs
were analyzed in 8% polyacrylamide gels. Bands were visualized
by autoradiography and quantitated by Scion Image software.
Transcription reactions with human 5S rRNA and tRNA
Tyr
genes were performed as previously described [10].
For reconstitution assays, recombinant proteins purified
through His-bind affinity chromatography columns [13] in folded
state were dialyzed against excess volumes of 16 transcription
buffer. The purity of the recombinant proteins were .95% as
determined by SDS/PAGE followed by coomassie blue staining.
Recombinant proteins at optimal concentration, 0.4 mg per 15 ml
of a newly prepared whole HeLa extract (,200 mg protein), were
then added to the extracts for 30 min on ice before the start of the
transcription reactions as specified above for each gene.
Nuclear run-on transcription assay
This assay was essentially performed as previously described by
Prieto and McStay 2007 [43]. Nuclei were treated with DNase
and Proteinase K and labeled RNA was isolated by phenol:chlor-
oform:isoamylalcohol extraction and was then hybridized to
probes immobilized on dot blots. The probes were pBluescript
carrying human 59ETS fragment of rDNA and 5S rRNA gene.
Western blot analysis and immunoprecipitation assays
Whole cell extracts or protein eluates from chromatography
columns were separated in 12% polyacrylamide/0.1% SDS gels.
Proteins were electrotransferred to nitrocellulose filters and
immunoblotted with primary antibodies in 1:100–400 dilution.
A 1:28,000 dilution of the corresponding secondary antibody was
used. Blots were washed and bands were visualized using the ECL
chemiluminescent kit, following instructions of the manufacturer
(Amersham).
RNase P from whole HeLa extracts was immunoprecipitated
with polyclonal anti-Rpp antibodies or with monoclonal and
polyclonal antibodies directed against Pol I, TAFI110, UBF, as
described [10]. Immunoprecipitates were assayed for RNase P
activity in processing of the 59 leader sequence of a
32P-labeled
precursor tRNA
Tyr in 16PA buffer mixed with 16TNET buffer
containing 2 mM Tris-HCl, pH 7.5, 35 mM NaCl, 0.1 mM
Na2EDTA, 1 mM 2-mercaptoethanol, 0.01% Triton X-100, 4 U
of rRNasin and 12 mg Poly I:C. Cleavage products were separated
in 8% polyacrylamide/7 M urea gel.
Chromatin immunoprecipitation analysis
ChIP analysis was done essentially as previously described [10].
Asynchronized or synchronized HeLa cells were collected, washed
with 16 PBS, and cross-linked with 0.5% NP-40/16 PBS
containing 1% formaldehyde for 10 min at 37uC. Cells were
rinsed with ice-cold 0.5% NP-40/16 PBS and incubated for
30 min in high-salt buffer (1 M NaCl, 0.5% NP-40, 16 PBS).
Cells were collected, washed with 0.5% NP-40/16PBS, and then
resuspended in low-salt buffer (0.1 M NaCl, 0.1% NP-40, 10 mM
Tris-HCl at pH 8.0, 1 mM EDTA). After 30 min, cells were
centrifuged at 4806g for 10 min and subjected to 10 strokes
through a 23-gauge needle. Nuclei obtained after centrifugation
were resuspended in low-salt buffer containing 2% sarkosyl and
transferred to a sucrose cushion (0.1 M sucrose, 0.1 M NaCl,
10 mM Tris-HCl at pH 8.0, 1 mM EDTA, 0.5% NP-40), and
then spun for 10 min at 40006g. The pellet was resuspended in
TE (10 mM Tris-HCl at pH 8.0, 1 mM EDTA) and spun again,
and genomic DNA was sheared by sonication (20630 sec, duty
cycle 80%) to produce stretches of chromatin of ,1000 base pairs
(bp) in length. In the experiment described in Figure 6D, the
genomic DNA was cut off to smaller pieces of ,500 bp. The
sonicated material was diluted in 1/10 volume of611 NET buffer
(1.65 M NaCl, 550 mM Tris-HCl at pH 7.4, 5.5 mM EDTA,
5.5% NP-40).
Sonicated material (0.2 ml per each immunoprecipitation) was
precleared for 30 min with 20 ml of Protein A/G Plus agarose
beads (Santa Cruz Biotechnology) and then blocked with 2 mgo f
salmon sperm (Invitrogen). After centrifugation, the sample was
subjected to IP overnight at 4uC using a nutating device with the
appropriate antibody coupled to beads (coupling was for 6 h at
4uC) and in the presence of 4 mg of salmon sperm. Precipitated
complexes were washed three times with 1 ml of RIPA buffer
(50 mM Tris-HCl at pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5%
deoxycholate, 1% NP-40), three times with 1 ml of LiCl buffer
(10 mM Tris-HCl at pH 8.0, 250 mM LiCl, 1 mM EDTA 0.5%
deoxycholate, 0.5% NP-40), and three times with 1 ml of TE.
Immunoprecipitated material was eluted twice with 200 mlo f1 %
SDS/TE and incubated overnight at 42uC in 0.4 ml volume of
elution buffer containing 120 mg/ml Proteinase K. DNA was
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v/v), ethanol-precipitated, washed with 70% ethanol, dried, and
resuspended in 25 mL distilled water for use in PCR analysis.
Each PCR reaction contained 2.5 mL of each primer (final
concentration of 1 mM), 5 mlo f1 0 6reaction mixture, and 4 mlo f
DNA for each IP sample. Input DNA was diluted in distilled water
before PCR. PCR amplification programs and primer sequences for
5S rRNA, tRNA
Tyr,U 1s n R N A ,A R P PP 0w e r ed e s c r i b e d[ 1 0 ] .
Primers for promoter rDNA were described in Philimonenko et al.
2004 [32]. Primers for 5.8S rDNA were 59- CGACTCTTA-
GCGGTGGATCAC-39 and 59-AAGCGACGCTCAGACAG-
GCGT-39, for 18S rDNA: 59-CCTTTAACGAGGATCCA-
TTGGA-39 and 59-GACACTCAGCTAAGA GCATCGAG -39,
for 28S rDNA: 59-CTCTTCCTATCATTGTGAAGCAG-39 and
59-CAAATGTCTGAACCTGCGGTTC-39 and for IGS: 59-
TGTTCTTGGGGGTGGGTTGAC-39 and 59-GAAGAGGTTC-
CGATGGGAAGTTG-39.
RNase H digestion assay
Targeting the H1 RNA for specific cleavage by RNase H has
been previously described [10]. Whole HeLa extract (15 ml; 10–
15 mg/ml; not diluted) was incubated with 8 mg of H1-1 or
scrambled H1-1sc deoxyoligonucleotide (Sigma, Israel) and 40
units of E. coli RNase H (Takara Bio, Inc.) for 45 min at 30uCi na
final volume of 25 ml. The effect of this treatment on RNase P
activity in the extracts was determined by examining 59-end
processing of
32P-labeled E. coli precursor tRNA
Tyr and
separation of the cleavage products in an 8% sequencing gel. An
aliquot of 15 ml from each treated extract was then tested for in
vitro transcription of mini-rRNA and small noncoding RNA genes
as described above.
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